Cited by 58Diabetes Management and ResearchDiabetes and associated disordersDiabetes Management and Education

Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes: HbA1c and hypoglycemia risk

Open access
Karges, Beate, Kapellen, Thomas, Wagner, Verena M, Steigleder-Schweiger, Claudia, Karges, Wolfram, Holl, Reinhard W, Rosenbauer, Joachim, for the DPV Initiative·2017·Pediatric Diabetes

Abstract

OBJECTIVE: To assess the risk of severe hypoglycemia related to glycated hemoglobin A1c (HbA1c) levels in a population-based cohort of pediatric type 1 diabetes patients during two time periods since 1995. METHODS: The association between HbA1c levels and severe hypoglycemia (defined as requiring assistance from another person) or hypoglycemic coma (loss of consciousness or seizures) was analyzed by multivariable regression analysis in children and adolescents with type 1 diabetes from the DPV Diabetes Prospective Follow-up in Germany and Austria in 1995-2003 (n = 15 221 patients) and 2004-2012 (n = 22 318 patients). RESULTS: Mean adjusted rates of severe hypoglycemia and hypoglycemic coma decreased from 19.18 [95% confidence interval (CI), 17.95-20.48] and 4.36 (3.93-4.83) per 100 patient-years in 1995-2003 to 15.01 (14.18-15.88) and 2.15 (1.94-2.39) in 2004-2012, respectively (p < 0.001). From the first to the second period, the relative risk (RR) for severe hypoglycemia and hypoglycemic coma per 1% lower HbA1c decreased from 1.22 (1.15-1.30) to 1.06 (1.01-1.12) and from 1.27 (1.15-1.40) to 1.04 (0.94-1.16), respectively. Risk of severe hypoglycemia and coma declined most in patients with HbA1c levels of 6-6.9% (RR 0.70 and 0.43, respectively) and with HbA1c of 7-7.9% (RR 0.63 and 0.38, respectively). Mean HbA1c levels fell from 8.4% in 1995-2003 to 8.2% in 2004-2012, while the use of insulin pumps, short- and long-acting insulin analogs, and glucose monitoring increased (p < 0.001). CONCLUSIONS: In contrast to 1995-2003, low HbA1c has become a minor risk factor for severe hypoglycemia and coma in pediatric patients with type 1 diabetes in the 2004-2012 period.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pedi.12348

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CGM and other advanced diabetes technologies allow HbA1c to reach target without raising severe hypoglycaemia risk.

    “with CGM and other advanced diabetes technologies HbA1c can be lowered into the target range without increasing the risk of severe hypoglycaemia.114”

    From Type 1 diabetes (2018) · cites this paper as [114]

    The Discussion says that children and adolescents with type 1 diabetes may be able to achieve optimal HbA1c targets without increased severe hypoglycemia risk. It does not establish that CGM or other advanced technologies enable this: the authors explicitly say that which devices or treatment approaches contributed remains unresolved. Page numbers are unavailable in our copy. (LLM, conf=0.89)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karges, B., Kapellen, T., Wagner, V. M., Steigleder-Schweiger, C., Karges, W., Holl, R. W., Rosenbauer, J., & Initiative, F. T. D.
Affiliations
  • German Center for Diabetes Research (DE)
  • University Hospital Leipzig (DE)
  • University of Lübeck (DE)
  • Department of Pediatrics; Paracelsus Medical University Salzburg; Salzburg Austria
  • Division of Endocrinology and Diabetes, Medical Faculty; RWTH Aachen University, German Center for Diabetes Research (DZD); Aachen Germany
  • Universität Ulm (DE)
  • Deutsches Diabetes-Zentrum e.V. (DE)
Corresponding author
Karges, Beate
Venue
Pediatric Diabetes
Publisher
Wiley
Published
2015-12-29
Volume
18
Issue
1
Pages
51-58
ISSN
1399-543X (ISSN-L)
OpenAlex
W2215008771
Cited by
58
References
34
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 3
FWCI
5.78
Type
journal article
Language
en
Open access
Locations
  • Pediatric Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
Bundesministerium für Bildung und Forschung (FKZ 01GI1106, 01GI1109B)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
HbA1c, severe hypoglycemia, hypoglycemic coma, type 1 diabetes in children, glycemic control, HbA1c trends, hypoglycemia risk factors, children and adolescents, diabetes complications, HbA1c thresholds
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Diabetes Mellitus, Type 1, Diabetic Coma, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Infant, Male, Risk Factors, Severity of Illness Index, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review